Preview
Quality on Sale
02/28/2026Oakmark Funds’ David Herro and Tony Coniaris describe how they marry quality and price in searching for ideas, the process changes they’ve made over the past year, how they try to navigate markets characterized by “amplified price volatility," and why they're seeing mispriced upside in Bayer, Siemens Healthineers, IMCD and LVMH Moët Hennessy.
If you are a subscriber, log in to access the issue and bonus archive:
- To subscribe, please visit our subscription page.
- To buy this single issue now, please click here.